Autoantibody Profiles: SLE, RA, Vasculitis — MRCP Part 1
- Crack Medicine

- 2 days ago
- 3 min read
TL;DR:
Autoantibody questions are high-yield and predictable in MRCP Part 1. Examiners repeatedly test recognition of disease-specific antibodies, their prognostic value, and classic pitfalls. This article distils the key autoantibody profiles in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and vasculitis, with an exam-style case and a practical revision checklist.
Why this topic matters for MRCP Part 1
Autoantibodies bridge immunology, rheumatology, nephrology, and respiratory medicine—core MRCP territory. Unlike vague symptom questions, these are pattern-recognition marks. If you can match antibody → disease → organ involvement, you score quickly.
Authoritative guidance on MRCP content and exam structure is published by the MRCP(UK) diploma board:https://www.mrcpuk.org/
Scope: what the exam actually tests
MRCP Part 1 focuses on:
Disease-defining antibodies
Antibodies predicting severity or organ involvement
Differentiation between similar conditions
Common false assumptions (deliberate traps)
You are not expected to memorise rare research antibodies.
High-yield autoantibody profiles (exam table)
Condition | Key autoantibodies | What examiners want you to know |
SLE | ANA, anti-dsDNA, anti-Smith | dsDNA correlates with disease activity; anti-Smith is highly specific |
Antiphospholipid syndrome | Lupus anticoagulant, anticardiolipin | Thrombosis + prolonged APTT paradox |
Rheumatoid arthritis | RF, anti-CCP | Anti-CCP predicts severe, erosive disease |
Granulomatosis with polyangiitis (GPA) | c-ANCA (PR3) | ENT + lung + kidney involvement |
Microscopic polyangiitis (MPA) | p-ANCA (MPO) | Pulmonary-renal syndrome |
Eosinophilic granulomatosis with polyangiitis (EGPA) | p-ANCA (±) | Asthma + eosinophilia |
Exam pearl: Anti-dsDNA levels rise during SLE flares, especially with lupus nephritis.
The 5 most tested subtopics
1) ANA ≠ lupus
ANA is sensitive, not specific
Up to 20% of healthy people may have low-titre ANA
Diagnosis requires clinical features + specific antibodies
Reference:https://www.nice.org.uk/guidance/ng137
2) Anti-dsDNA and renal disease in SLE
Strong association with lupus nephritis
Levels correlate with disease activity
Often tested alongside low complement (C3, C4)
3) Anti-CCP vs rheumatoid factor
RF: sensitive, but non-specific (seen in infections, elderly)
Anti-CCP: highly specific and prognostic
Guideline summary (British Society for Rheumatology):https://www.rheumatology.org.uk/Portals/0/Documents/Guidelines/RA/Guidelines_for_the_management_of_RA.pdf
4) ANCA patterns matter
c-ANCA (PR3) → GPA
p-ANCA (MPO) → MPA
Trap: Assuming p-ANCA always equals EGPA.
5) Antiphospholipid antibodies cause clotting
Lupus anticoagulant prolongs APTT in vitro
Causes thrombosis in vivo
Authoritative review:https://www.ncbi.nlm.nih.gov/books/NBK539864/

Mini-case (MRCP style)
A 30-year-old woman presents with photosensitive rash, arthralgia, and new-onset proteinuria. Blood tests show low C3 and C4.
Which antibody is most likely to rise during disease flare?
A. Anti-SmithB. ANAC. Anti-dsDNAD. Anti-CCPE. Rheumatoid factor
Correct answer: C — Anti-dsDNA
Explanation: Anti-dsDNA correlates with disease activity and lupus nephritis. ANA is useful for screening, not monitoring.
Common pitfalls (examiner favourites)
Treating ANA positivity as diagnostic of SLE
Confusing RF specificity with anti-CCP
Forgetting dsDNA tracks lupus activity
Mixing up p-ANCA–associated diseases
Missing antiphospholipid syndrome in young stroke patients
Practical study-tip checklist
☐ Learn one antibody per disease first, then layer details
☐ Link antibodies to organ systems (kidney, lung, joints)
☐ Practise with vignettes, not isolated facts
☐ Re-test tables every 7 days (spaced repetition)
☐ Use NICE and MRCP(UK)-aligned sources only
FAQs
Is ANA always positive in SLE?
No. ANA is highly sensitive but not universal, and it lacks specificity.
Which antibody predicts severe rheumatoid arthritis?
Anti-CCP is most predictive of aggressive, erosive disease.
Does p-ANCA always mean vasculitis?
No. p-ANCA can be seen in inflammatory bowel disease and other conditions.
Which antibody best tracks lupus activity?
Anti-dsDNA correlates best with disease flares and nephritis.
Ready to start?
Ready to turn autoantibody recognition into guaranteed MRCP Part 1 marks?
👉 Practise exam-level questions now with the Crack Medicine MRCP QBank:https://crackmedicine.com/qbank/
👉 Test yourself under real exam conditions using full-length mock tests:https://crackmedicine.com/mock-tests/
👉 Reinforce concepts fast with clinician-led MRCP video lectures:https://crackmedicine.com/lectures/
Sources
MRCP(UK) Examination guidance – https://www.mrcpuk.org/
NICE SLE guideline (NG137) – https://www.nice.org.uk/guidance/ng137
British Society for Rheumatology RA guidance – https://www.rheumatology.org.uk/
Kumar & Clark’s Clinical Medicine
Oxford Handbook of Rheumatology



Comments